<p>Edgestream Partners L.P. 在第二季度购买了 Pediatrix Medical Group, Inc. (NYSE:MD - 免费报告) 的新股份，根据其最近向证券交易委员会提交的 13F 表格。该公司购买了 53,175 股该公司的股票，价值约为 763,000 美元。截至其最近向证券交易委员会提交的文件，Edgestream Partners L.P. 拥有 Pediatrix Medical Group 0.06% 的股份。</p>
<ul>
<li>美敦力股票找到立足点——现在正在获得动能</li>
</ul>
<p>其他机构投资者和对冲基金最近也对该公司的持仓进行了调整。波士顿合伙公司在第一季度将其在 Pediatrix Medical Group 的持股增加了 1.3%。波士顿合伙公司现在拥有 1,981,889 股该公司的股票，价值 27,990,000 美元，在上个季度又收购了 25,536 股。美国世纪公司在第二季度将其在 Pediatrix Medical Group 的持仓提高了 28.6%。美国世纪公司现在拥有 1,931,867 股该公司的股票，价值 27,722,000 美元，在此期间又购买了 430,029 股。英维斯科有限公司在第一季度将其在 Pediatrix Medical Group 的股份增加了 9.3%。英维斯科有限公司现在拥有 863,269 股该公司的股票，价值 12,509,000 美元，在上个季度又购买了 73,157 股。Bridgeway Capital Management LLC 在第一季度将其在 Pediatrix Medical Group 的股份增加了 1.7%。Bridgeway Capital Management LLC 现在拥有 554,452 股该公司的股票，价值 8,034,000 美元，在此期间又购买了 9,007 股。最后，Nuveen LLC 在第一季度购买了 Pediatrix Medical Group 的新股份，价值约为 8,024,000 美元。机构投资者拥有该公司 97.71% 的股票。</p>
<h2>Pediatrix Medical Group 股票下跌 0.7%</h2>
<p>MD 股票在周五开盘价为 22.14 美元。该公司的债务与股本比率为 0.65，流动比率为 1.83，速动比率为 1.83。该股票的市值为 19 亿美元，市盈率为 11.65，贝塔值为 0.77。Pediatrix Medical Group, Inc. 的 52 周低点为 11.84 美元，52 周高点为 24.99 美元。该公司的 50 日移动平均线为 19.94 美元，200 日移动平均线为 16.47 美元。</p>
<ul>
<li>MarketBeat 周回顾 – 08/18 - 08/22</li>
</ul>
<p>Pediatrix Medical Group (NYSE:MD - 获取免费报告) 最近在 11 月 3 日星期一公布了其财报。该公司报告每股收益 (EPS) 为 0.67 美元，超出分析师共识预期的 0.46 美元，超出幅度为 0.21 美元。Pediatrix Medical Group 的股本回报率为 20.45%，净利润率为 8.44%。该公司在本季度的收入为 4.9288 亿美元，而分析师预期为 4.7645 亿美元。去年同期，该公司每股收益为 0.44 美元。Pediatrix Medical Group 本季度的收入较去年同期下降了 3.6%。平均而言，卖方分析师预计 Pediatrix Medical Group, Inc. 在当前财年将发布每股收益 1.38 美元。</p>
<h2>内部活动</h2>
<p>在其他 Pediatrix Medical Group 的新闻中，董事 Michael A. Rucker 于 11 月 17 日星期一出售了 10,478 股该公司的股票。该股票以平均价格 23.00 美元出售，总交易额为 240,994.00 美元。交易后，该董事持有 59,101 股该公司的股票，价值 1,359,323 美元。此次交易使其持股减少了 15.06%。该交易已在向证券交易委员会提交的文件中披露，相关文件可通过此链接获取。此外，董事 Laura A. Linynsky 于 11 月 6 日星期四出售了 10,000 股该公司的股票。该股票以平均价格 21.65 美元出售，总价值为 216,500.00 美元。交易后，该董事直接持有 32,232 股该公司的股票，价值 697,822.80 美元。此次交易使其持股减少了 23.68%。有关此次出售的更多细节可在官方 SEC 披露中找到。公司内部人士拥有该公司 0.90% 的股票。</p>
<h2>华尔街分析师预测增长</h2>
<ul>
<li>美敦力：收入投资者的机会变得更健康</li>
</ul>
<p>一些股票分析师对该股票发布了报告。Wall Street Zen 在 10 月 4 日星期六的研究报告中将 Pediatrix Medical Group 的股票评级从 “买入” 上调至 “强力买入”。Leerink Partners 在 9 月 5 日星期五的研究报告中将 Pediatrix Medical Group 的目标价从 14.50 美元上调至 17.00 美元，并给予该股票 “市场表现” 评级。Weiss Ratings 在 12 月 1 日星期一的报告中重申了对 Pediatrix Medical Group 股票的 “持有 (c+)” 评级。Zacks Research 在 11 月 21 日星期五的报告中将 Pediatrix Medical Group 的评级从 “持有” 上调至 “强力买入”。最后，瑞银集团在 11 月 5 日星期三的研究报告中将 Pediatrix Medical Group 的目标价从 16.50 美元上调至 23.00 美元，并给予该公司 “中性” 评级。一位股票研究分析师对该股票给予了强力买入评级，一位给予了买入评级，四位给予了持有评级。根据 MarketBeat 的数据，Pediatrix Medical Group 目前的平均评级为 “适度买入”，平均目标价为 21.00 美元。</p>
<p><strong>获取我们关于 MD 的最新报告</strong></p>
<h2>Pediatrix Medical Group 公司简介</h2>
<p>(免费报告)</p>
<p>Pediatrix Medical Group, Inc. 及其子公司在美国提供新生儿、母胎、儿科心脏病学及其他儿科专科护理服务。它提供新生儿护理服务，例如通过新生儿医学专科医生、新生儿护士执业者和其他儿科临床医生在医院特定病房内为早产或有并发症的婴儿提供临床护理。</p>
<h2>推荐故事</h2>
<ul>
<li>我们更看好的五只股票，而非 Pediatrix Medical Group</li>
<li>ETF 是否支付股息？你需要知道的事项</li>
<li>Ulta 的股票可能会迎来上涨——未来有 20% 的上涨空间？</li>
<li>消费品股票解析</li>
<li>比尔·盖茨基金会出售 MSFT 股票——投资者应该担心吗？</li>
<li>如何知道该购买哪种加密货币：投资者指南</li>
<li>MarketBeat 周度回顾 – 12/1 - 12/5</li>
</ul>
<p><strong>想看看其他对 MD 持有的对冲基金吗？</strong> 访问 HoldingsChannel.com 获取 Pediatrix Medical Group, Inc. (NYSE:MD - 免费报告) 的最新 13F 文件和内部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1E?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1E"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Pediatrix Medical Group 吗？</h2>
<p>在考虑 Pediatrix Medical Group 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，而 Pediatrix Medical Group 并不在名单上。</p>
<p>虽然 Pediatrix Medical Group 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

<p>Edgestream Partners L.P. 投资了 Pediatrix Medical Group，购买了 53,175 股，价值 763,000 美元。其他投资者调整了他们的持股，波士顿合伙人、美国世纪公司等增加了他们的股份。Pediatrix 报告了强劲的收益，超出了分析师的预期，并获得了华尔街分析师的积极评级。公司内部人士出售了股份，减少了他们的持仓。该股票的市值为 19 亿美元，市盈率为 11.65。分析师预测增长，华尔街 Zen 给出了强买评级</p>

<p>Edgestream Partners L.P. bought a new stake in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 53,175 shares of the company's stock, valued at approximately $763,000. Edgestream Partners L.P. owned 0.06% of Pediatrix Medical Group as of its most recent filing with the Securities and Exchange Commission.</p>
<div class="lb-trans"><p>Edgestream Partners L.P. 在第二季度购买了 Pediatrix Medical Group, Inc. (NYSE:MD - 免费报告) 的新股份，根据其最近向证券交易委员会提交的 13F 表格。该公司购买了 53,175 股该公司的股票，价值约为 763,000 美元。截至其最近向证券交易委员会提交的文件，Edgestream Partners L.P. 拥有 Pediatrix Medical Group 0.06% 的股份。</p>
</div><ul>
<li>Medtronic Stock Finds Its Footing—Now It’s Gaining Momentum</li>
</ul>
<div class="lb-trans"><ul>
<li>美敦力股票找到立足点——现在正在获得动能</li>
</ul>
</div><p>Other institutional investors and hedge funds also recently made changes to their positions in the company. Boston Partners boosted its holdings in Pediatrix Medical Group by 1.3% in the first quarter. Boston Partners now owns 1,981,889 shares of the company's stock valued at $27,990,000 after acquiring an additional 25,536 shares during the last quarter. American Century Companies Inc. lifted its position in Pediatrix Medical Group by 28.6% during the 2nd quarter. American Century Companies Inc. now owns 1,931,867 shares of the company's stock valued at $27,722,000 after purchasing an additional 430,029 shares during the period. Invesco Ltd. boosted its stake in shares of Pediatrix Medical Group by 9.3% in the 1st quarter. Invesco Ltd. now owns 863,269 shares of the company's stock valued at $12,509,000 after purchasing an additional 73,157 shares during the last quarter. Bridgeway Capital Management LLC grew its position in shares of Pediatrix Medical Group by 1.7% during the 1st quarter. Bridgeway Capital Management LLC now owns 554,452 shares of the company's stock worth $8,034,000 after buying an additional 9,007 shares during the period. Finally, Nuveen LLC bought a new stake in shares of Pediatrix Medical Group during the first quarter worth approximately $8,024,000. Institutional investors own 97.71% of the company's stock.</p>
<div class="lb-trans"><p>其他机构投资者和对冲基金最近也对该公司的持仓进行了调整。波士顿合伙公司在第一季度将其在 Pediatrix Medical Group 的持股增加了 1.3%。波士顿合伙公司现在拥有 1,981,889 股该公司的股票，价值 27,990,000 美元，在上个季度又收购了 25,536 股。美国世纪公司在第二季度将其在 Pediatrix Medical Group 的持仓提高了 28.6%。美国世纪公司现在拥有 1,931,867 股该公司的股票，价值 27,722,000 美元，在此期间又购买了 430,029 股。英维斯科有限公司在第一季度将其在 Pediatrix Medical Group 的股份增加了 9.3%。英维斯科有限公司现在拥有 863,269 股该公司的股票，价值 12,509,000 美元，在上个季度又购买了 73,157 股。Bridgeway Capital Management LLC 在第一季度将其在 Pediatrix Medical Group 的股份增加了 1.7%。Bridgeway Capital Management LLC 现在拥有 554,452 股该公司的股票，价值 8,034,000 美元，在此期间又购买了 9,007 股。最后，Nuveen LLC 在第一季度购买了 Pediatrix Medical Group 的新股份，价值约为 8,024,000 美元。机构投资者拥有该公司 97.71% 的股票。</p>
</div><h2>Pediatrix Medical Group Stock Down 0.7%</h2>
<div class="lb-trans"><h2>Pediatrix Medical Group 股票下跌 0.7%</h2>
</div><p>MD stock opened at $22.14 on Friday. The company has a debt-to-equity ratio of 0.65, a current ratio of 1.83 and a quick ratio of 1.83. The stock has a market capitalization of $1.90 billion, a P/E ratio of 11.65 and a beta of 0.77. Pediatrix Medical Group, Inc. has a fifty-two week low of $11.84 and a fifty-two week high of $24.99. The business has a 50-day moving average of $19.94 and a 200-day moving average of $16.47.</p>
<div class="lb-trans"><p>MD 股票在周五开盘价为 22.14 美元。该公司的债务与股本比率为 0.65，流动比率为 1.83，速动比率为 1.83。该股票的市值为 19 亿美元，市盈率为 11.65，贝塔值为 0.77。Pediatrix Medical Group, Inc. 的 52 周低点为 11.84 美元，52 周高点为 24.99 美元。该公司的 50 日移动平均线为 19.94 美元，200 日移动平均线为 16.47 美元。</p>
</div><ul>
<li>MarketBeat Week in Review – 08/18 - 08/22</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 08/18 - 08/22</li>
</ul>
</div><p>Pediatrix Medical Group (NYSE:MD - Get Free Report) last announced its earnings results on Monday, November 3rd. The company reported $0.67 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.46 by $0.21. Pediatrix Medical Group had a return on equity of 20.45% and a net margin of 8.44%.The business had revenue of $492.88 million for the quarter, compared to analyst estimates of $476.45 million. During the same quarter last year, the firm earned $0.44 EPS. Pediatrix Medical Group's revenue for the quarter was down 3.6% compared to the same quarter last year. On average, sell-side analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Pediatrix Medical Group (NYSE:MD - 获取免费报告) 最近在 11 月 3 日星期一公布了其财报。该公司报告每股收益 (EPS) 为 0.67 美元，超出分析师共识预期的 0.46 美元，超出幅度为 0.21 美元。Pediatrix Medical Group 的股本回报率为 20.45%，净利润率为 8.44%。该公司在本季度的收入为 4.9288 亿美元，而分析师预期为 4.7645 亿美元。去年同期，该公司每股收益为 0.44 美元。Pediatrix Medical Group 本季度的收入较去年同期下降了 3.6%。平均而言，卖方分析师预计 Pediatrix Medical Group, Inc. 在当前财年将发布每股收益 1.38 美元。</p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>内部活动</h2>
</div><p>In other Pediatrix Medical Group news, Director Michael A. Rucker sold 10,478 shares of the business's stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $23.00, for a total transaction of $240,994.00. Following the transaction, the director owned 59,101 shares of the company's stock, valued at $1,359,323. The trade was a 15.06% decrease in their position. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available through this link. Also, Director Laura A. Linynsky sold 10,000 shares of the business's stock in a transaction that occurred on Thursday, November 6th. The stock was sold at an average price of $21.65, for a total value of $216,500.00. Following the transaction, the director directly owned 32,232 shares in the company, valued at $697,822.80. The trade was a 23.68% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 0.90% of the company's stock.</p>
<div class="lb-trans"><p>在其他 Pediatrix Medical Group 的新闻中，董事 Michael A. Rucker 于 11 月 17 日星期一出售了 10,478 股该公司的股票。该股票以平均价格 23.00 美元出售，总交易额为 240,994.00 美元。交易后，该董事持有 59,101 股该公司的股票，价值 1,359,323 美元。此次交易使其持股减少了 15.06%。该交易已在向证券交易委员会提交的文件中披露，相关文件可通过此链接获取。此外，董事 Laura A. Linynsky 于 11 月 6 日星期四出售了 10,000 股该公司的股票。该股票以平均价格 21.65 美元出售，总价值为 216,500.00 美元。交易后，该董事直接持有 32,232 股该公司的股票，价值 697,822.80 美元。此次交易使其持股减少了 23.68%。有关此次出售的更多细节可在官方 SEC 披露中找到。公司内部人士拥有该公司 0.90% 的股票。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><ul>
<li>Medtronic: The Opportunity Gets Healthier for Income Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>美敦力：收入投资者的机会变得更健康</li>
</ul>
</div><p>A number of equities analysts have issued reports on the stock. Wall Street Zen raised shares of Pediatrix Medical Group from a &#34;buy&#34; rating to a &#34;strong-buy&#34; rating in a research note on Saturday, October 4th. Leerink Partners raised their price target on Pediatrix Medical Group from $14.50 to $17.00 and gave the stock a &#34;market perform&#34; rating in a research report on Friday, September 5th. Weiss Ratings reiterated a &#34;hold (c+)&#34; rating on shares of Pediatrix Medical Group in a report on Monday, December 1st. Zacks Research upgraded Pediatrix Medical Group from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a report on Friday, November 21st. Finally, UBS Group upped their price target on Pediatrix Medical Group from $16.50 to $23.00 and gave the company a &#34;neutral&#34; rating in a research note on Wednesday, November 5th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat, Pediatrix Medical Group presently has an average rating of &#34;Moderate Buy&#34; and an average price target of $21.00.</p>
<div class="lb-trans"><p>一些股票分析师对该股票发布了报告。Wall Street Zen 在 10 月 4 日星期六的研究报告中将 Pediatrix Medical Group 的股票评级从 “买入” 上调至 “强力买入”。Leerink Partners 在 9 月 5 日星期五的研究报告中将 Pediatrix Medical Group 的目标价从 14.50 美元上调至 17.00 美元，并给予该股票 “市场表现” 评级。Weiss Ratings 在 12 月 1 日星期一的报告中重申了对 Pediatrix Medical Group 股票的 “持有 (c+)” 评级。Zacks Research 在 11 月 21 日星期五的报告中将 Pediatrix Medical Group 的评级从 “持有” 上调至 “强力买入”。最后，瑞银集团在 11 月 5 日星期三的研究报告中将 Pediatrix Medical Group 的目标价从 16.50 美元上调至 23.00 美元，并给予该公司 “中性” 评级。一位股票研究分析师对该股票给予了强力买入评级，一位给予了买入评级，四位给予了持有评级。根据 MarketBeat 的数据，Pediatrix Medical Group 目前的平均评级为 “适度买入”，平均目标价为 21.00 美元。</p>
</div><p><strong>Get Our Latest Report on MD</strong></p>
<div class="lb-trans"><p><strong>获取我们关于 MD 的最新报告</strong></p>
</div><h2>Pediatrix Medical Group Company Profile</h2>
<div class="lb-trans"><h2>Pediatrix Medical Group 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免费报告)</p>
</div><p>Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.</p>
<div class="lb-trans"><p>Pediatrix Medical Group, Inc. 及其子公司在美国提供新生儿、母胎、儿科心脏病学及其他儿科专科护理服务。它提供新生儿护理服务，例如通过新生儿医学专科医生、新生儿护士执业者和其他儿科临床医生在医院特定病房内为早产或有并发症的婴儿提供临床护理。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than Pediatrix Medical Group</li>
<li>Do ETFs Pay Dividends? What You Need to Know</li>
<li>Ulta’s Stock May Be Set for a Glow-Up—20% Upside Ahead?</li>
<li>Consumer Staples Stocks, Explained</li>
<li>Gates Foundation Sells MSFT Stock—Should Investors Be Worried?</li>
<li>How to Know Which Cryptocurrency to Buy: A Guide for Investors</li>
<li>MarketBeat Week in Review – 12/1 - 12/5</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，而非 Pediatrix Medical Group</li>
<li>ETF 是否支付股息？你需要知道的事项</li>
<li>Ulta 的股票可能会迎来上涨——未来有 20% 的上涨空间？</li>
<li>消费品股票解析</li>
<li>比尔·盖茨基金会出售 MSFT 股票——投资者应该担心吗？</li>
<li>如何知道该购买哪种加密货币：投资者指南</li>
<li>MarketBeat 周度回顾 – 12/1 - 12/5</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding MD?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pediatrix Medical Group, Inc. (NYSE:MD - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对 MD 持有的对冲基金吗？</strong> 访问 HoldingsChannel.com 获取 Pediatrix Medical Group, Inc. (NYSE:MD - 免费报告) 的最新 13F 文件和内部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1E" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=MD"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Pediatrix Medical Group Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Pediatrix Medical Group 吗？</h2>
</div><p>Before you consider Pediatrix Medical Group, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Pediatrix Medical Group 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pediatrix Medical Group wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，而 Pediatrix Medical Group 并不在名单上。</p>
</div><p>While Pediatrix Medical Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Pediatrix Medical Group 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Edgestream Partners L.P. 对 Pediatrix Medical Group, Inc. $MD 进行了新的投资